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Using AI to Diagnose COVID-19  
 from Patient Chest CT Scans 
Kenneth Richardson, Liang Huang, Joe Jiang, Sam Arellano, and Omar Youssef 
Master of Science in Data Science, Southern Methodist University, 
Dallas, TX 75275 USA 
Abstract. Rapid and accurate detection of COVID-19 remains the best weapon 
to control and prevent the spread of this pandemic, at least before a vaccine or 
treatment is available. In this study, we trained our custom computer vision 
models to predict COVID-19 from patients’ CT scans. We trained one model 
using Google’s AutoML Vision platform and achieved comparable accuracy 
with previously reported models. We also trained several custom models using 
transfer learning by taking advantage of several well-unknown pre-trained 
computer vision models, including Resnet and Inception models. The models are 
fine-tuned with a relatively large dataset and their high accuracy should make 
them more generalizable for potential clinical application. 
1   Introduction 
Shortly after being reported in Wuhan China in early December 2019, the World 
Health Organization (WHO) declared COVID-19 a global health emergency on 
January 30, 2020, and subsequently a global pandemic on March 11, 2020 [1]. Since 
then, SARS-Cov-2, the virus that causes the disease has proved to be highly 
contagious and reported to be capable of asymptomatic transmission. According to 
figures from John Hopkins University, as of November 12, 2020, the number of 
confirmed COVID-19 cases has reached 52.8 million worldwide with over 10.6 
million of the cases in the US alone [2]. Currently, there are no Food and Drug 
Administration (FDA) approved vaccines or therapeutics for the treatment of COVID-
19 patients. However, there have been varying degrees of social distancing measures 
implemented to limit the spread of the virus. The Centers for Disease Control and 
Prevention (CDC) recommends that people wear a face mask to cover their nose and 
mouth. The intention of recommending a face covering in communities is not only for 
the wearer’s protection but also to minimize the spread of the virus from the wearer to 
others. This is especially important in the case of asymptomatic individuals that are 
infected but show no flu-like symptoms [3]. Despite stringent public health measures 
and efforts to encourage social distancing, the virus appears to still be spreading 
rapidly around the world. 
As COVID-19 is caused by the SARS-CoV-2 retrovirus, the common method to 
diagnose patients is through the use of RNA detection methods that are based on 
reverse transcription followed by polymerase chain reaction (RT-PCR). This PCR-
based test is relatively unreliable, and as the stock of tests is still in fairly short supply 
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and increasingly high demand, they are not always readily available to healthcare 
agencies.  Furthermore, these tests can have a low sensitivity ranging from 65%-95% 
giving them false-negative rates of up to 35%, meaning that in some cases up to a 
third of the tests indicated a patient was COVID-19 negative even though the patient 
was infected with the disease [4]. 
Although several approaches to diagnose COVID-19 using patient’s CT scans 
have been reported, they are not without challenges. Given the high demand, the 
number of CT scans needed to be examined, and the limited number of radiologists 
available to examine and diagnose them; manual diagnosis of CT scans has presented 
a considerable bottleneck. Therefore, an artificial intelligence-based approach is an 
appealing alternative for rapidly diagnosing patients.  
Multiple studies have attempted to use machine learning and artificial intelligence 
to help diagnose the CT scans retrospectively. The number of images in the datasets 
used by these studies ranges from 106 to 5941 [5]. The sensitivity and accuracy of the 
reported models range from 0.8-1.0 and 0.65-1.0 respectively [6-8]. However, the 
conclusions are not without controversy with multiple professional medical societies 
strongly opposed to the use of AI to diagnose CT scans [9]. While our primary 
hypothesis is to test the feasibility of using AI to diagnose COVID-19 patients, we are 
equally interested in identifying the potential pitfalls of using this approach in the 
medical field. 
The literature review section of this paper discusses the related published work. It 
includes early COVID-19 symptoms, primary methods of detection, and previously 
attempted uses of machine learning and artificial intelligence to diagnose COVID-19. 
Section 2.1 (SARS-CoV-2) describes in detail the symptoms of COVID-19, Reverse 
Transcription and Polymerase Chain Reaction (RT-PCR) method to detect the viruses, 
and the most common feature in COVID-19 infected lung CT scans, Ground Glass 
Opacity (GGO). Section 2.2 (Deep Learning vs. Traditional ML) introduces the 
history of CAD systems and expounds upon recent advances using deep learning to 
detect COVID-19. Section 3 (Data) describes the dataset acquisitions.  Section 4 
(Methods) describes the advantages of using the Auto ML Platform.  Section 5 
(Results) provides results of Auto ML and Pytorch Custom Models. Lastly, Section 6 
(Discussion) summarizes our findings and conclusions.   
2   Related Work 
2.1    SARS-CoV-2  
A growing body of research has identified bats as the evolutionary source of the 
SARS-CoV-2 virus. The current hypothesis is that the first transmission of the SARS-
CoV-2 virus occurred when the virus jumped from bats to humans [10]. The virus was 
then transmitted from human to human thus becoming a global health crisis.  The 
reported early symptoms of COVID-19 are cough, shortness of breath, fever, and 
other related flu-like symptoms with some infected patients never experiencing any of 
these and remaining asymptomatic. Unfortunately, significant portions of the infected 
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patients develop a lower respiratory tract infection (LRTI) that may require 
hospitalization. Furthermore, with an average death rate of 2%-5%, the SARS-CoV-2 
virus has a much higher mortality rate than the coronaviruses that result in the 
common cold. The disease also spreads much faster than the coronavirus that caused 
the prior SARS outbreak. One key to prevent the further spread of COVID-19 hinges 
on finding reliable ways to diagnose patients rapidly.  
The current primary method of diagnosing patients is based on the detection of 
viral RNA by Reverse Transcription and Polymerase Chain Reaction method (RT-
PCR), commonly known as PCR testing. The upper respiratory samples, including 
nasopharyngeal swabs, oropharyngeal swabs, nasal aspirates, and nasopharyngeal 
washes, are broadly recommended. For patients exhibiting productive cough, lower 
respiratory samples, including sputum, BAL fluid, and tracheal aspirates, are 
recommended [11]. Unfortunately, if the virus is not accumulated in the swabbed 
areas, the tests may fail to diagnose a COVID-19 patient correctly.  According to one 
study, SAR-CoV-2 could be reliably detected in sputum followed by nasal swabs in 
the first 14 days after onset, whereas throat swabs were unreliable 8 days after on-set. 
The reliability problem presents a challenge to correctly identifying COVID patients 
with earlier tests yielding only about 70% accuracy. Given the variability in viral 
loads, a negative test result from a respiratory sample does not rule out the disease. 
Furthermore, in some cases, the false-negative rates can be up to 35%, rending the test 
useless [11].  While some of these false negatives could stem from improper sampling 
techniques, the false negatives can also arise from where the viral loads are low, or 
mutations in the viral genome. Another big challenge is the lack of sufficient 
diagnostic kits at medical facilities in many countries. Even with government 
intervention, the stock of PCR tests is still in relatively short supply. This has resulted 
in a backlog of tests in some cases. The problem is further compounded by the long 
wait time for test results to come back from the lab. As a result, urgent treatments for 
patients with acute illness may be delayed. In addition, several PCR tests might be 
needed to correctly diagnose this disease, resulting in delayed patients treatment and 
quarantine.       
Among the clinical manifestations of virus infection, ground-glass opacity (GGO) 
pattern is the most common feature in COVID-19 infected lung CT scans. These 
patterns are usually multifocal, bilateral, and peripheral, but may present as a unifocal 
lesion in the early phase of the disease, commonly located in the lobe of the right 
lung. In the later stage of the disease where there is a thickened interlobular and 
intralobular lines in combination with a GGO pattern called “crazy paving” [12].  
Given these prominent features, computed tomography (CT) lung scans have become 
a fast alternative method to diagnose patients with COVID-19 [13].  Chest CT scans 
are non-invasive and are used to take X-ray measurements at different angles across a 
patient’s chest to produce cross-sectional images. Radiologists who analyze these 
images will look for abnormal features that can help lead to a COVID diagnosis. 
Several retrospective studies have shown that the CT scans have a higher sensitivity 
and better false-negative rates diagnosing COVID-19 when compared to PCR testing.  
However, as imaging features overlap with other viral pneumonia, the specificity can 
be low [14]. Below are sample chest CT scan images of confirmed COVID-19 
patients. 
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Fig 1.  59-year male with confirmed COVID-19 [14]. However, the PCR-test result was a false-
negative.  The arrow indicates areas of ground-glass opacity (GGO) and massive consolidation 
in the posterior parts of the lower lobes. 
2.2 Deep Learning vs. Traditional ML 
Computer vision using transfer learning for deep learning has become one of the most 
popular applications in the world of AI for medical imaging.  Transfer learning aims 
to optimize the pre-trained CNN models to the custom datasets and objectives. In 
practice, the last layer of the pre-trained models is replaced by a custom layer suited 
for the specific task.  The advantages of transfer learning are two-fold, first, the model 
training is fast because the majority of the model parameters are frozen and 
unchanged during training; second, perhaps more importantly, because the frozen 
layers have already learned to recognize features, training a custom model only 
requires several hundred to several thousand images, instead of the millions of images 
required for training a CNN model from scratch.  
An early use of traditional machine learning was introduced in scientific literature 
a half-century ago.  Lodwick, a medical doctor from Iowa first introduced the term 
CAD, “Computer-Aided Diagnosis” this term in 1966. He developed a system for 
predicting the prognosis of lung cancer patients by their posterior, anterior, and lateral 
chest radiographs. His general approach was to convert visual images on 
roentgenograms into numerical sequences that could be manipulated and evaluated by 
the digital computer [15]. Today we call this method “training a classifier” with 
feature vectors. Although serious attempts at CAD development began in the 1980s, 
the CAD systems have only recently become an inseparable part of routine clinical 
practice. In particular, these systems have assisted radiologists in detecting lung 
abnormalities. The predictions from these systems are not only reproducible but also 
capable of detecting subtle changes that are easily missed by visual inspection [16].    
In this study, a proposed CAD system based on deep learning was implemented to 
distinguish COVID-19 from non-COVID-19 lung infections. 510 COVID-19 and 510 
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non-COVID-19 image patches were extracted from CT slices by a radiologist and 
were used train on ten different pre-trained computer vision models, including 
AlexNet, VGG-16, VGG-19, SqueezeNet, GoogleNet, MobilNetV2, ResNet-18, 
ResNet-50, ResNet-101, and Xception. Five performance indices, including 
Accuracy, Sensitivity, Specificity, Positive Predictive Value (PPV), Negative 
Predictive Value (NPV), and the SUC scores were used to compare the diagnosis 
from the models and the radiologists themselves. The overall AUC scores range from 
0.894-0.994. The AUC score from the radiologist's diagnosis was 0.873 with 89.21% 
sensitivity, 83.33% specificity, 86.27% accuracy, 84.25% PPV, and 88.54% NPV. 
Based on the image patches, the radiologist had worse performance with a 0.603 
AUC, 61.76% sensitivity, 58.82% specificity, 60.29% accuracy, 60.00% PPV, and 
60.61% NPV [13], suggesting that there is great potential for computer vision model 
to improve the current COVID-19 diagnosis through chest CT scans [16]. Among the 
pre-trained CNN models, ResNet-101 and Xception have been shown to have the best 
performance in training CT images to diagnose COVID-19 patients.  
Another recent paper reported a Lesion-Attention Deep Neural Network (LA-
DNN) model developed by researchers from Hong Kong University to predict 
COVID-19 positive or negative from a richly annotated chest CT image dataset.  The 
CT image dataset contains 746 public chest CT images of COVID-19 patients 
collected from over 760 preprints, and the data annotations are accompanied by the 
textual radiology reports. Two types of information were extracted from the images, 
the first is whether an image indicates a positive or negative case of COVID-19, and 
the other is the description of five types of lesions on the CT images associated with 
the positive cases. The proposed data-driven LA-DNN model focuses on the primary 
task of binary classification for COVID-19 diagnosis, while an auxiliary multi-label 
learning task is implemented simultaneously to draw the model's attention to the five 
types of lesions during the training. The joint task learning process makes it a highly 
sample-efficient deep learning model that can learn COVID-19 radiology features 
effectively with very limited samples [17].  
The Dutch Radiological Society developed the Coronavirus Disease 2019 
(COVID-19) Reporting and Data System (CO-RADS) based on other efforts for 
standardization, such as the Lung Imaging Reporting and Data System or Breast 
Imaging Reporting and Data System. CO-RADS assesses the suspicion for pulmonary 
involvement of COVID-19 on a scale from 1 (very low) to 5 (very high). The system 
is meant to be used in patients with moderate to severe symptoms of COVID-19. The 
system was evaluated using 105 chest CT scans of patients admitted to the hospital 
with clinical suspicion of COVID-19 and in whom PCR test was performed (mean, 62 
years ± 16 [standard deviation]; 61 men, 53 with positive PCR results). Eight 
observers used CO-RADS to assess the scans. Fleiss κ value was calculated, and 
scores of individual observers were compared with the median of the remaining seven 
observers. The resulting area under the receiver operating characteristics curve (AUC) 
was compared with results from the PCR test and clinical diagnosis of COVID-19.  
CO-RADS performs very well in predicting COVID-19 in patients with moderate to 
severe symptoms and has a substantial interobserver agreement, especially for 
categories 1 and 5 [18]. 
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3   Data 
We identified a number of potential datasets that are available from different 
resources [19]. After research and trials, we allocated 3 datasets for our study these 
are summarized in (Table 1).  
Table 1.  Sources of CT Scans for custom COVID-19 prediction models  
 




This dataset contains 314 samples of 
COVID-19 positive and COVID-19 
negative CT scans from patients. [20] 
Total of 314 Images 
 135 COVID 
179 Non-COVID 
MosMed COVID 
19 CT Scans 
This dataset contains anonymized human 
lung computed tomography (CT) scans 
with COVID-19 related findings, as well 
as without such findings. In total, there 
are 1000 CT scans each from a unique 
patient. [21] 
20 Patients 





This dataset was collected from real 
patients in hospitals from Sao Paulo, 
Brazil[22]. 
Total 2482 CT 
Scans, 1252 positives 
and 1230 negative 
for COVID-19 
 
One of the datasets is a blend of 2D images from Tongji Hospital, Wuhan, China [20]. 
A senior radiologist released this dataset and has addressed questions and comments 
from researchers around the world. The major concerns are summarized as follows. 
First, when the original CT images are put into papers, the quality of these images is 
degraded, which may render the diagnosis decisions less accurate. The quality 
degradation includes: the Hounsfield Unit (HU) values are lost; the number of bits per 
pixel is reduced; the resolution of images is reduced. Second, the original CT scan 
contains a sequence of CT slices, but when put into papers, only a few key slices are 
selected, which may have a negative impact on the diagnosis as well.  
However, the issues raised in these concerns do not appear to significantly affect 
the accuracy of diagnosis. First, experienced radiologists are able to make an accurate 
diagnosis from low-quality CT images. For example, given a photo taken by a 
smartphone of the original CT image, experienced radiologists can make an accurate 
diagnosis by just looking at the photo, though the CT image in the photo has much 
lower quality than the original CT image. Likewise, the quality gap between CT 
images in papers and original CT images does not appear to hurt the accuracy of 
diagnosis. Second, while it is preferable to read a sequence of CT slices, oftentimes a 
slice of CT contains enough clinical information for accurate decision-making. 
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4   Methods 
This study plans to take advantage of transfer learning in computer vision and train a 
custom COVID-19 classifier using several pre-trained models in the PyTorch 
torchvision library; including resnet50, resnet101, and inception_v3.  Fine-tuning 
these pre-trained models will be part of the process by freezing all the layers except 
the last fully connected layer (fc), which will then be replaced with a sigmoid layer 
for binary classification. Google AutoML vision will be used as a benchmark to 
compare to our custom model to make predictions from CT scans. This platform 
automatically reshuffles the images and assigns them into train, validation, and test 
datasets. The system will then output the most suitable/ accurate model. For model 
evaluation, not only the overall accuracy (precision and recall) are provided, but also 
a confusion matrix will be generated in a visual format that provides insights into the 
model performance.  One of the most appealing aspects of the AutoML platform is its 
ease to deploy the final trained model and make predictions on test images right away.  
However, you can also download the model and similarly deploy it locally or on other 
platforms. The added benefit is that we’re able to design a custom user interface for 




Fig 2.  Sketch of Google AutoML Vision. The platform allows direct model training from 
images and convenient deployment on Google Cloud Platform.   
 
Following are methods used to process original CT images before feeding to the 
designed DNN pipelines. U-Net is a convolutional neural network that was developed 
for biomedical image segmentation at the Computer Science Department of the 
University of Freiburg, Germany. U-Net is used to do lung segmentation. Pre masked 
lesion images are used to train neural networks to do lesion masking. Once we get the 
cropped lesion image, we use image augmentation techniques on them. 
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Fig 3.  Pre masked lesion images are used to train neural networks to do lesion 
masking. 
5   Results 
5.1    AutoML Model 
 
Even without the labeling of lesions and with limited data, our current models trained 
on the Google AutoML vision platform have already reached a similar level of 
precision and recall rate in cited published research papers. These results from Google 
AutoML will be used as a benchmark to compare with our custom trained models 
described in detail in the following section. Briefly, the process of training an 
AutoML model first involves uploading the images to Google Cloud Platform (GCP) 
in a data storage bucket, including both COVID and Non-COVID CT images in two 
different folders. Then using a Jupyter notebook, a data index CSV file was created to 
link the images and their label (folder name) to their google bucket path. 
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Fig 4.  Chest CT images imported to Google AutoML Vision Platform. The platform allows 
direct model training from images and deployment on Google Cloud Platform with minimal 
input from the users.   
 
The next step is to use the index file to import the images as a dataset [20] into the 
Google AutoML platform (Figure 4). The platform automatically divides the images 
into training testing datasets to allow direct model training. Depending on the selected 
parameters, such as the desired precision level, the training itself can take as long as 
16 node hours. After the model training has finished, a simple metric summarizes the 
model’s precision and recall scores, which help us understand how accurate the model 
is. With an average precision score of 0.97, our AutoML model is already on par with 
the published models.   
Another useful model metric is the area under the precision-recall curve. It 
measures how well your model performs across all score thresholds. In AutoML 
Vision, this metric is called Average Precision (Figure 5).  
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Fig 5.  The precision and recall scores of our AutoML model. 
   
A more direct evaluation of the model performance is provided by a confusion matrix 
(Table 2). From the confusion matrix, we can see that the model performs extremely 
well on recognizing the COVID-19 CT images, but does poorly on Non-COVID CT 
scans, only correctly recognizing 78% of the images as Non-COVID.  
 





Non-COVID-19 78%(14/18) 22%(4/18) 
COVID-19 0%(0/13) 100%(13/13) 
 
 
5.2    Pytorch Custom Models 
 
We also took advantage of transfer learning in computer vision and trained our 
custom COVID-19 classifier using several pre-trained models in the torchvision 
library, including resnet50, resnet101, and inception_v3. We fine-tuned these models 
by freezing all the layers except the last fully connected layer (fc), which we replaced 
with a binary classification layer. We used a large dataset from Sao Paulo that 
contains around 2500 CT scans and trained the models for 200 epochs and the Resnet-
50 model’s training and validation loss and accuracy curves are shown (Fig. 6).  
10




Fig 6. The training and validation loss (left) and accuracy (right) of Resnet-50 
models. The model was trained for 200 epochs on Google Collab. 
 
The Resnet-50 model confusion matrix is shown (Table 3). The model has a high 
precision rate of 96.8% but suffers from a relatively high false-positive rate at 10.4%. 
Given the potential impact of misdiagnosed asymptomatic carriers on the continued 
spread of COVID-19, reducing the false-negative rate is critical.    
 
Table 3. Resnet-50 model confusion matrix. The model has a high recall rate but 





COVID-19 96.8%(122/126) 3.2%(4/126) 
Non-COVID-19 10.4%(11/106) 89.6%(95/106) 
 
The architecture of the Resnet-50 model and test accuracies of the three custom 
models are summarized in Fig. 8. Among the three models, we have similar test 
accuracies. Though Resnet50 had the highest model test accuracy, Resnet-101 
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Fig. 8. Training custom models using transfer learning.  A. The architecture of pre-
trained Resnet-50 vision model with the last layer modifier to diagnose COVID-19 
from CT scans [16]. B. The test accuracies of three different custom-trained models.  
 
6   Discussion  
 
6.1 Limitations  
 
Both our AutoML vision and custom models’ performance metrics were on par with 
that of the published COVID-19 prediction models. However, there are at least three 
potential limitations concerning the results of this study. The first limitation is that our 
model training was completely dependent on publicly available datasets.  There are 
conflicting claims about whether these datasets reflect the reality of all potential 
COVID-19 infected patients.  Many infected COVID-19 patients are asymptomatic, 
and it is unclear to what degree these patients share the symptoms seen in the CT lung 
scans of hospitalized patients. This complicates the practical usage of CT lung scans 
and these diagnostic models as a frontline tool for diagnosing COVID-19 as we lack 
comparative scans of COVID-positive asymptomatic patients.  A second limitation of 
this study is that there were no criteria provided for which lung position CT scanned 
image should be used for training the model and for predicting the patient’s COVID-
19 status. Though, the study did attempt to synthesize all the images from each 
patient’s CT scans and extract features from those scans to train a prediction model. A 
third limitation is the overlapping symptoms that COVID-19 patients share with lung 
infections such as bronchitis and pneumonia.  This may explain why models that 
focused on the binary classification of COVID-19 tended to have higher false-positive 
rates than models that focused on differentiating between the three conditions.  
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Despite these limitations, our findings highlight that trained models can achieve 
levels of precision that match and exceed those of experienced radiologists. Using 
these models alongside the established work of the Dutch Radiological Society could 
lead to computer vision assisted CO-RADS. This would allow for the training models 
that can determine the severity of COVID-19 using a standardized scale. Thus 
allowing allow health care professionals to accurately diagnose the degree of infection 
so that the appropriate level of care could be administered in a timely manner, 
increasing the chances of a patient’s recovery.  
  
6.2    Future Research 
 
As the spread of COVID-19 continues into winter, hospitals will likely find 
themselves treating a variety of respiratory illnesses concurrently. While our models 
focused primarily on determining whether a patient had COVID-19 or not, our models 
could be trained to differentiate between different types of respiratory diseases.  
 In addition to expanding the predictive capability of our models, it would be useful 
to extend the current findings by examining an integrated deep learning algorithms 
pipeline. The pipeline would encapsulate the best practices of producing transfer 
learning image classification models that include lung segmentation, lesion detection, 
masking, and lesion image augmentation. Furthermore, this pipeline would simulate 
the processing of CT scans with automated image data streaming in a sequential end-
to-end workflow.  
 COVID-19 is still a relatively new disease and though a vaccine seems ever more 
likely, the high rate at which SARS-CoV-2 has been observed to mutate and its 
accelerated spread around the world may be indicators that COVID-19 will be 
pervasive if not perennial disease. As such, continued research into the viability of 
computer-aided diagnosis using CT scans along with the development of standardized 
metrics and processes may be a key to easing the burden of already taxed medical 
infrastructures.          
 
7   Conclusion   
 
The results of our research suggest that while the application of these models as 
frontline diagnostic tools may not be practical or effective, their use as diagnostic 
tools for hospitalized patients has great potential. Even with a vaccine, we anticipate 
that COVID-19 will be a concern into the near future and may potentially evolve into 
a seasonal if not perennial health risk. The implementation of these models as part of 
computer-aided diagnosis pipelines and their integration into current diagnostic 
practices may help make the identification of COVID-19 more efficient. This study 
shows that custom trained computer vision models can accurately predict COVID-19 
infections and suggests that if implemented alongside a standardized workflow, they 
could greatly benefit overburdened radiology departments resulting in improved 
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